4-Chlorobenzo[F]isoquinoline (CBIQ), a novel activator of CFTR and ΔF508 CFTR

European Journal of Pharmacology

Volumn 516, Issue 2, 2005, Pages 118-124

  Murthy, Meena ^a   Pedemonte, Nicoletta ^b   MacVinish, Lesley ^a   Galietta, Luis ^b   Cuthbert, Alan ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

CFTR (Cystic fibrosis transmembrane conductance regulator); Chloride channel; Chloride secretion; Cystic fibrosis; Intermediate conductance calcium sensitive potassium channel; KCNN4

Indexed keywords

4 CHLOROBENZ[F]ISOQUINOLINE; BENZO[F]QUINOLINE; BENZO[H]QUINOLINE; CHLORIDE CHANNEL; ISOQUINOLINE DERIVATIVE; POTASSIUM CHANNEL; QUINOLINE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SECRETION; CONDUCTANCE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; HETEROLOGOUS EXPRESSION; MUTANT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; ISOQUINOLINES; MEMBRANE POTENTIALS; MICROINJECTIONS; OOCYTES; PHENANTHROLINES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; QUINOLINES; RATS; RATS, INBRED F344; RNA, COMPLEMENTARY; THYROID GLAND; XENOPUS LAEVIS;

EID: 20444409680     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.037     Document Type: Article

References (18)

1. F. Becq, Y. Mettey, M.A. Gray, L.J.V. Galietta, R.L. Dormer, M. Merton, M. Metaye, V. Chappe, C. Marvingt-Mounir, O. Zegarra-Moran, R. Tarran, L. Bulteau, R. Derand, M.M.C. Pereira, M.A. Mcpherson, C. Rogier, M. Joffre, B.E. Argent, D. Sarrouilhe, W. Kammouni, C. Figarella, B. Verrier, M. Gola, and J.M. Vierfond Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel J. Biol. Chem. 274 1999 27415 27425
2. - channel activity J. Biol. Chem. 280 2005 5221 5226
3. E. Caci, C. Folli, O. Zegarra-Moran, T. Ma, M.F. Springsteel, R.E. Sammelson, M.H. Nantz, M.J. Kurth, A.S. Verkman, and L.J.V. Galietta CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds Am. J. Physiol. 285 2003 L180 L188
4. - channels in human lung epithelia: activation by arachidonic acid, amidation, and acid activated omeprazole Am. J. Physiol. 281 2001 C46 C54
5. A.W. Cuthbert Benzoquinolines and chloride secretion in murine colonic epithelium Br. J. Pharmacol. 138 2003 1528 1534
6. A.W. Cuthbert, and L.J. MacVinish Mechanisms of anion secretion in Calu-3 human epithelial cells by 7,8-benzoquinoline Br. J. Pharmacol. 140 2003 81 90
7. A.W. Cuthbert, C.T. Supuran, and L.J. MacVinish Bicarbonate-dependent chloride secretion in Calu-3 epithelia in response to 7,8-benzoquinoline J. Physiol. 551 2003 79 92
8. R. Dearand, L. Bulteau-Pignoix, and F. Becq Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004 J. Membr. Biol. 194 2003 109 117
9. G.M. Denning, M.P. Anderson, J.F. Amara, J. Marshall, A.E. Smith, and M.J. Welsh Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive Nature 358 1992 761 764
10. + channel Am. J. Physiol. 271 1996 L775 L784
11. M. Duszyk, L.J. MacVinish, and A.W. Cuthbert Phenanthrolines-a new class of CFTR chloride channel openers Br. J. Pharmacol. 134 2001 853 864
12. J.F. Engelhardt, J.R. Yankaskas, S.A. Ernst, Y. Yang, C.R. Marino, R.C. Boucher, J.A. Cohn, and J.M. Wilson Submucosal glands are the predominant site of CFTR expression in human bronchus Nat. Genet. 2 1992 240 248
13. L.J.V. Galietta, M.F. Springsteel, M. Eda, E.J. Niedzinski, K. By, M.J. Haddadin, M.J. Kurth, M.H. Nantz, and A.S. Verkman Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds J. Biol. Chem. 276 2001 19723 19728
14. T. Ma, L. Vetrivel, H. Yang, N. Pedemonte, O. Zegarra-Moran, L.J.V. Galietta, and A.S. Verkman High affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening J. Biol. Chem. 277 2002 37235 37241
15. C. Marivingt-Mounir, C. Norez, R. Derand, L. Bulteau-Pignoix, D. Nguyen-Huy, B. Viossat, G. Morgant, F. Becq, J.-M. Vierfond, and Y. Mettey Synthesis, SAR, crystal structure and biological activation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels J. Med. Chem. 47 2004 962 972
16. 2+-dependent Biochim. Biophys. Acta 1420 1999 231 240
17. M.F. Springsteel, L.J.V. Galietta, T. Ma, K. By, G.O. Berger, H. Yang, C.W. Dicus, W. Choung, C. Quan, A.A. Shelat, R.K. Guy, A.S. Verkman, M.J. Kuth, and M.H. Nantz Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: Towards a pharmacophore model for the nucleotide-binding domain Bioorg. Med. Chem. 11 2003 4113 4120
18. A.J. Szkotak, M. Murthy, L.J. MacVinish, M. Duszyk, and A.W. Cuthbert 4-Chloro-benzo[F]isoquinoline (CBIQ) activates CFTR chloride channels and KCNN4 potassium channels in Calu-3 human airway epithelial cells Br. J. Pharmacol. 142 2004 531 542